NEW YORK (GenomeWeb) – Advanced Cell Diagnostics today said that it has raised $22 million in a Series C equity financing. 

The Hayward, California-based company will use the financing to accelerate its entry into the research and clinical diagnostics markets and to launch new technology platforms based on its RNAscope technology. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.